Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Brain Effects of Gamma Frequency Sensory Stimulation (40Hz Light, Sound and Other Devices)

NCT: NCT07496918 · RECRUITING

NCT IDNCT07496918
StatusRECRUITING
Start Date2018-02-20
Completion2027-01-30

Brief Summary

Despite the huge healthcare and economic impact of AD, there is still no disease modifying therapeutics available. In fact, the available therapeutics show low efficacy at best in the treatment of cognitive impairment in dementia. Development of a non-invasive medical device that is effective in slowing cognitive impairment is not only revolutionary but also possibly cost- effective. In this study, participants will come to MIT for a 1-day visit and the investigators will evaluate the effects of GENUS in cognitively normal, healthy adults. Investigators will use Electroencephalogram (EEG), Magnetoencephalography (MEG), magnetic resonance imaging (MRI), neuropsychological testing, and blood sampling in subsets of participants to evaluate for biological effects and safety of GENUS stimulation.

Frequently Asked Questions

What is Brain Effects of Gamma Frequency Sensory Stimulation (40Hz Light, Sound and Other Devices)?

Brain Effects of Gamma Frequency Sensory Stimulation (40Hz Light, Sound and Other Devices) is a clinical trial registered under NCT07496918. Current status: RECRUITING.

What is the status of NCT07496918?

The current status of NCT07496918 (Brain Effects of Gamma Frequency Sensory Stimulation (40Hz Light, Sound and Other Devices)) is: RECRUITING.

When did Brain Effects of Gamma Frequency Sensory Stimulation (40Hz Light, Sound and Other Devices) start?

Brain Effects of Gamma Frequency Sensory Stimulation (40Hz Light, Sound and Other Devices) started on 2018-02-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.